J B Chemicals and Pharmaceuticals Quarterly Results for Trading Insights
JBCHEPHARM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹208 Cr
QSept 2025
J B Chemicals and Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹1,100 Cr in Sept 2025 (+14.1% vs Mar 2025, +8.8% vs Sept 2024)
- Net Profit of ₹208 Cr in Sept 2025 (+42.5% vs Mar 2025, +18.9% vs Sept 2024)
- EBITDA of ₹325 Cr in Sept 2025 (+34.9% vs Mar 2025)
- Operating Margin of 29.0% in Sept 2025 (+5.0pp vs Mar 2025)
- Earnings Per Share of ₹13.29 in Sept 2025 (+42.0% vs Mar 2025)
J B Chemicals and Pharmaceuticals Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 1,100 | 964 | 1,109 | 1,011 | 878 | 14.1% | 8.8% |
| Net Profit (₹ Cr) | 208 | 146 | 202 | 175 | 126 | - | - |
| EBITDA (₹ Cr) | 325 | 241 | 315 | 281 | 215 | - | - |
| EPS (₹) | 13.29 | 9.36 | 12.99 | 11.24 | 8.22 | - | - |
| Operating Margin (%) | 29.0% | 24.0% | 28.0% | 27.0% | 23.0% | - | - |
J B Chemicals and Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize J B Chemicals and Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in J B Chemicals and Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for J B Chemicals and Pharmaceuticals
Additional stock information and data for JBCHEPHARM
Revenue Trend (₹ Cr)
Sept 2024
1,011
Jun 2025
1,109
Mar 2025
964
Sept 2025
1,100
Net Profit Trend (₹ Cr)
Sept 2024
175
Jun 2025
202
Mar 2025
146
Sept 2025
208
Operating Margin Trend (%)
Sept 2024
27.0%
Jun 2025
28.0%
Mar 2025
24.0%
Sept 2025
29.0%
Sector Competitors - Quarterly Performance Comparison
Comparing J B Chemicals and Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores